Whole blood selenium levels (WBSL) in patients with prostate cancer (PC), benign prostatic hyperplasia (BPH) and healthy male inhabitants (HMI) and prostatic tissue selenium levels (PTSL) in patients with PC and BPH
/in International Publications, Micronutrients, Prostate Cancer /von 2009-01-01 / Acta Oncol 2009;48(3):452-6Dendritic cell vaccines for the treatment of prostate cancer
/in International Publications, Prostate Cancer /von 2008-11-01 / Urol. Oncol. 2008 Nov-Dec;26(6):576-80A two-state cell damage model under hyperthermic conditions: theory and in vitro experiments
/in Hyperthermia, International Publications, Prostate Cancer /von 2008-08-01 / J Biomech Eng 2008 Aug;130(4):041016Therapeutic dendritic cell vaccine preparation using tumor RNA transfection: a promising approach for the treatment of prostate cancer
/in International Publications, Prostate Cancer /von 2008-01-18 / Genet Vaccines Ther 2008 Jan;6:2Dendritic cells transduced with a PSMA-encoding adenovirus and cocultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against prostate cancer cells
/in International Publications, Prostate Cancer /von 2008-01-14 / Urol. Oncol. 2009 Jan-Feb;27(1):26-32Prostate cancer vaccines: current status and future potential
/in International Publications, Prostate Cancer /von 2008-01-01 / BioDrugs 2008;22(2):71-84Immunotherapy for metastatic prostate cancer
/in International Publications, Prostate Cancer /von 2007-12-21 / Urol. Oncol. 2008 Jul-Aug;26(4):438-44Advances in specific immunotherapy for prostate cancer
/in International Publications, Prostate Cancer /von 2007-11-26 / Eur. Urol. 2008 Apr;53(4):694-708Localized hyperthermia combined with intratumoral dendritic cells induces systemic antitumor immunity
/in Dendritic Cells, Hyperthermia, International Publications, Prostate Cancer /von 2007-08-15 / Cancer Res. 2007 Aug;67(16):7798-806
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de